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Abstract Background: Hip hemiarthroplasty is a well-
established treatment of displaced femoral neck fracture,
although debate exists over whether cemented or
uncemented fixation is superior. Uncemented prostheses
have typically been used in younger, healthier patients and
cemented prostheses in older patients with less-stable bone.
Also, earlier research has suggested that bone cement has
cytotoxic effects and may trigger cardiovascular and respi-
ratory adverse events. Questions/Purposes: The aim of this
systematic review and meta-analysis was to compare mor-
bidity and mortality rates after cemented and uncemented
hemiarthroplasty for the treatment of displaced femoral neck
fractures in elderly patients. Methods: Using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines, we searched seven medical databases
for randomized clinical trials and observational studies. We
compared cemented and uncemented hemiarthroplasty
using the Harris Hip Score (HHS), as well as measures of
postoperative pain, mortality, and complications. Data were
extracted and pooled as risk ratios or standardized mean
difference with their corresponding 95% confidence inter-
vals in a meta-analysis model. Results: The meta-analysis
included 34 studies (12 randomized trials and 22 observa-
tional studies), with a total of 42,411 patients. In the pooled
estimate, cemented hemiarthroplasty was associated with
less risk of postoperative pain than uncemented
hemiarthroplasty. There were no significant differences be-
tween groups regarding HHS or rates of postoperative mor-
tality, pulmonary embolism, cardiac arrest, myocardial
infarction, acute cardiac arrhythmia, or deep venous
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thrombosis. Conclusions: While we found that cemented
hemiarthroplasty results in less postoperative pain than
uncemented hemiarthroplasty in older patients with femoral
neck fracture, the lack of significant differences in function-
al hip scores, mortality, and complications was surprising.
Further high-level research is needed.
Keywords Hip hemiarthroplasty .Cemented.
Uncemented.Mortality .Morbidity
Introduction
Displaced femoral neck fractures are associated with persis-
tent hip pain, disability, and high morbidity and mortality
rates, significantly affecting quality of life [4, 5, 18]. Debate
continues over the selection of prosthesis to be used for
hemiarthroplasty [3, 28, 40, 43, 54, 55, 56].
Historically, the use of uncemented femoral components
has been indicated in younger-elderly patients with relative-
ly good bone quality, although disadvantages include higher
risks of thigh pain and periprosthetic fracture [27, 40].
Cemented femoral components are typically used in elderly
patients with poor bone quality and are associated with less
thigh pain and stem loosening [53], but they have been
associated with higher risks of cardiac events, deep venous
thrombosis (DVT), and pulmonary embolism as a result of
bone cement implantation syndrome [1, 19, 38, 39, 40, 65].
Various studies have reported that bone cement can have
cytotoxic effects and mediate procoagulant activities, which
could trigger cardiovascular and respiratory events, the main
causes of death in elderly patients with reduced reserve
capacity [14, 15, 19].
Consequently, we conducted a systematic review andmeta-
analysis to compare the rates of mortality and complications,
including pulmonary embolism, cardiac arrest, myocardial in-
farction, acute cardiac arrhythmia, and DVT, after cemented
and uncemented hemiarthroplasty used for the treatment of
displaced femoral neck fractures in older patients.
Methods
We followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement
(www.prisma-statement.org) as our guide during the prepara-
tion of this systematic review and meta-analysis. Moreover, all
steps were performed in strict accordance with the Cochrane
Handbook of Systematic Reviews of Interventions [33].
We performed electronic searches of PubMed, the
Cochrane Central Register of Controlled Trials (CEN-
TRAL), Scopus, Embase, EBSCO, Ovid, and Web of Sci-
ence in May of 2017, using the following keywords:
“hemiarthroplasty,” “arthroplasty,” “femoral neck frac-
tures,” “intracapsular hip fractures,” “hip prosthesis,”
“cemented,” “cementless,” and “uncemented.”We modified
terms as necessary to suit each database and applied no
restrictions of publication date. We also searched the US
clinical trial registry (www.clinicaltrials.gov) for additional
ongoing and unpublished studies and searched the reference
lists in eligible studies for relevant articles not otherwise
identified.
We included randomized clinical trials and observational
studies that met the following inclusion criteria: the study en-
rolled patients over 65 years who underwent surgery for
displaced femoral neck fractures, the intervention was
hemiarthroplasty with a cemented or uncemented (cementless)
prosthesis, and the study compared the outcomes of cemented
and uncemented hemiarthroplasty.
We excluded reviews, case reports, and duplicates, as
well as studies in which patients had had a previous fracture
of the same hip or a pathological fracture, in which an
animal model was used, or that were not in English. Eligi-
bility screening was conducted in two steps, each by three
independent reviewers: title and abstract screening for
matching the inclusion criteria and full-text screening to
determine eligibility for meta-analysis. Disagreements were
resolved by a third reviewer.
The outcomes of interest included hip function as
assessed by the Harris Hip Score (HHS) [31, 50], postoper-
ative pain, medical outcomes (including pulmonary embo-
lism, cardiac arrest, myocardial infarction, acute cardiac
arrhythmia, and DVT), and mortality rates at 1 month,
3 months, and 1 year after surgery.
Data were extracted from the included studies by three
independent researchers using Microsoft Excel. Disagree-
ments were resolved by discussion and consensus among
senior researchers. Extracted data included first author, pub-
lication year, study design, number of participants in each
group, mean age, sex, type of intervention, study period,
follow-up period, and outcomes of interest. For the random-
ized clinical trials, we used the Cochrane Collaboration’s
tool for assessing the risk of bias [33]. For observational
studies, we used the Newcastle–Ottawa Scale for assessing
the quality of observational studies [66], and each included
study was assessed according to reporting of three essential
domains: selection of the study subjects; comparability of
groups, in terms of demographic characteristics and impor-
tant potential confounders; and ascertainment of the
prespecified outcome (exposure/treatment). To assess the
risk of bias across the included studies, we compared the
reported outcomes between all studies to exclude selective
reporting of outcomes.
Data Analysis
We calculated risk ratios (RRs) with 95% confidence
intervals (CIs) for dichotomous outcomes and standard-
ized mean difference (SMD) with 95% CI for continuous
data. Heterogeneity was assessed using the Cochran Q
test, χ2 test for Q statistic distribution, and the I2 test.
We performed the meta-analysis using a fixed-effect mod-
el if no significant heterogeneity was present (I2 < 50%;
p > 0.1). Otherwise, we adopted the random-effect model.
Egger’s test and the trim-and-fill method were used to
assess the possibility of publication bias. Data analyses
were performed using the R software “meta” package,
version 4.9–2 (R Foundation, Vienna, Austria), for
HSSJ
Windows. A p value of < 0.05 was considered statistically
significant.
Results
The literature search yielded 871 unique records. Upon
screening of titles and abstracts, 50 articles were retrieved
and screened for eligibility. Of these, 34 articles were in-
cluded in the meta-analysis. The study selection process is
shown in the PRISMA flow diagram (Fig. 1).
Of the 34 studies included in our analysis, 12 were ran-
domized clinical trials [17, 20, 22, 25, 42, 55, 59, 60, 65, 68,
69, 73] and 22 were observational studies [2, 7, 9, 10, 24, 27,
29, 30, 35, 37, 40, 44, 47, 51, 52, 57, 61, 70, 72, 75–77]. The
34 included studies investigated a total of 42,411 participants;
among whom 32,385 underwent cemented hemiarthroplasty
and 10,026 underwent uncemented hemiarthroplasty
(Table 1). The risk of bias in the randomized clinical trials
was acceptable according to the Cochrane risk-of-bias assess-
ment (Fig. 2a). The observational studies achieved a mean of
7 out of 9 points on the Newcastle–Ottawa Scale, indicating a
moderate quality (Fig. 2b).
When the HHS was assessed (five studies: three random-
ized clinical trials and two observational studies), the overall
estimate showed no significant difference between the
cemented and uncemented hemiarthroplasty groups (SDM=
0.08; 95% CI, − 0.22, to 0.37; p = 0.81). This effect estimate
was consistent in subgroup analyses (Fig. 3) at follow-up times
of 3 months (SMD= 0.28; 95% CI, − 0.33 to 0.89; p = 0.23),
1 year (SMD= 0.07; 95% CI, − 0.40 to 0.53; p = 0.66), and
5 years (SMD= − 0.19; 95% CI, − 0.92 to 0.54; p = 0.17).
The cemented hemiarthroplasty group was found to have a
lower risk of postoperative pain. Eleven studies (seven ran-
domized clinical trials and four observational studies) report-
ed on postoperative pain (overall RR = 0.64; CI, 0.53 to 0.77;
p < 0.0001). This effect estimate remained consistent in sub-
group analyses according to study design (Fig. 4); no signif-
icant heterogeneity was observed (I2 = 25%; p = 0.21).
No significant differences in mortality were found be-
tween the cemented and uncemented hemiarthroplasty
groups at any duration of follow-up.
Fig. 1. Flow diagram of study selection
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Nine studies (four randomized clinical trials and five observa-
tional studies) reported on mortality at 1 month postoperatively.
There was no significant difference between the two groups
(RR=0.86; 95% CI, 0.61 to 1.21; p= 0.39); there was moderate
heterogeneity (I2 = 36%; p= 0.32). This result remained consistent
in subgroup analysis according to study design (Fig. 5a).
Six studies (four randomized clinical trials and two
observational studies) reported on mortality at 3 months
Fig. 2. a Risk-of-bias summary of randomized clinical trials, according to the Cochrane Collaboration’s tool for assessing the risk of bias [33]
and b risk-of-bias summary of observational studies, according to the Newcastle–Ottawa scale [66]
Fig. 3. Forest plot showing the standardized mean difference (SMD)
in Harris Hip Score between cemented and uncemented
hemiarthroplasty (with 95% confidence interval [CI])
Fig. 4. Forest plot showing the risk ratio (RR) of postoperative pain
between cemented and uncemented hemiarthroplasty (with 95% con-
fidence interval [CI])
HSSJ
postoperatively. The overall pooled RR did not favor either
of the two groups (RR = 0.87; 95% CI, 0.66 to 1.14; p =
0.31); there was no evidence of heterogeneity (I2 = 0%; p =
0.69). This result remained consistent in subgroup analysis
according to study design (Fig. 5b).
Data on mortality at 1 year postoperatively were reported in
13 studies (eight randomized clinical trials and five observa-
tional studies), with no significant difference between cemented
and uncemented hemiarthroplasty reported (RR = 0.92; 95%
CI, 0.80 to 1.06; p = 0.25) and no evidence of heterogeneity
(I2 = 0%; p = 0.82). This result remained consistent in subgroup
analysis according to study design (Fig. 5c). Egger’s test
showed no evidence of publication bias; p = 0.31.
No difference in the rates of pulmonary embolism or DVT
was found. Eight studies (two randomized clinical trials and six
observational studies) reported data on pulmonary embolism.
The overall RR did not favor either prosthesis type (RR = 1.13;
95% CI, 0.64 to 2.02; p = 0.67). This result remained true
regardless of study design. Pooled studies were homogeneous
(I2 = 0%; p = 0.70) (Fig. 6a). Eight studies reported data on
DVT (one randomized clinical trial and seven observational
studies). The overall RR did not differ significantly between the
two groups (RR = 0.85; 95% CI, 0.50 to 1.44; p =0.54); there
was no notable heterogeneity among these studies (I2 = 14%;
p = 0.32) (Fig. 6c).
No difference in the risk of cardiac complications was
found between the two groups. Two studies (one randomized
clinical trial and one observational study) reported on cardiac
arrest. The combined RR did not favor either of the two groups
(RR = 1.74; 95% CI, 0.13 to 23.19; p = 0.68). Pooled studies
were heterogeneous (I2 = 60%; p = 0.67). Similarly, the overall
RR in the eight studies reporting data on myocardial infarction
(three randomized clinical trials and five observational studies)
was comparable between the two groups (RR = 1.44; 95% CI,
0.73 to 2.86; p = 0.30). This result remained consistent in
subgroup analysis according to study design. The eight
pooled studies were homogeneous (I2 = 0%; p = 0.84)
(Fig. 6b). Two studies (one randomized clinical trial and one
observational study) provided data on acute cardiac arrhythmia.
The combinedRR did not favor either cemented or uncemented
hemiarthroplasty (RR = 0.57; 95% CI, 0.08 to 4.33; p = 0.59).
This effect estimate remained consistent in subgroup analysis
according to study design. No heterogeneity was observed
(I2 = 0%; p = 0.64).
Discussion
This study of 42,411 older adults showed no significant differ-
ences between cemented and uncemented hemiarthroplasty of
the hip in terms of HHS, mortality, or medical complications.
However, the results did reveal cemented fixation to be associ-
ated with less postoperative pain than uncemented fixation.
Similar to our results, those of a study from the Swedish
Hip Arthroplasty Register by Rogmark et al. showed no signif-
icant difference in mortality according to femoral fixation type
Fig. 5. a Forest plot showing the risk ratio (RR) of mortality at
1 month postoperatively between cemented and uncemented
hemiarthroplasty (with 95% confidence interval [CI]); b forest plot
showing the RR of mortality at 3 months postoperatively between
cemented and uncemented hemiarthroplasty (with 95% CI); c forest
plot showing the RR of mortality at 1 year postoperatively between
cemented and uncemented hemiarthroplasty (with 95% CI)
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at 1 year after surgery [58]. In addition, two recent meta-
analyses, one with five randomized clinical trials [71] and the
other with seven [46], reported no significant differences in
mortality related to type of fixation (cemented or uncemented)
1 year after surgery. In contrast, a study of data from an
Australian registry reported higher mortality on the first post-
operative day in patients with cemented prostheses but an
overall lower rate of death through 1 year of follow-up [12].
Several studies have described comorbidity, older age,
male sex, delayed surgery, and cognitive impairment as
some of the most important risk factors for death after hip
fracture [34, 36, 56, 62, 63, 67, 68]. Our patient population
may lack the reserve capacity that is essential to handle the
double trauma of a hip fracture and subsequent surgery.
Therefore, the more severe the comorbidity, the higher the
risk of a fatal outcome when cementation is applied; these
factors, of course, influence the selection of the method of
fixation [68]. Nevertheless, recent improvements in surgical
techniques, the careful elimination of any cellular debris and
blood clots from the medullary canal before inserting the
bone cement, perioperative monitoring of patients by an
experienced anesthesia team, and thromboprophylaxis may
well have improved the survival of hip surgery patients [21,
26, 32, 43, 64, 69] and help explain our results regarding
mortality at 1 month, 3 months, and 1 year after surgery.
Earlier research has suggested that cemented femoral
components in hip replacement surgery in patients with
femoral neck fractures are associated with cardiovascular
complications, including embolism and arrhythmia [22, 23,
45, 48, 65]. Nevertheless, our study found no differences
between cemented and uncemented hemiarthroplasty in
rates of postoperative myocardial infarction, acute arrhyth-
mia, cardiac arrest, or pulmonary embolism. Our findings
are supported by meta-analyses conducted by Li et al., Lin
et al., and Luo et al., which found no differences in major
postoperative complications between patients with
cemented and cementless stems [46, 47, 49].
High risks of DVT after cemented hip and knee
arthroplasty have been reported in earlier studies [13, 41,
49]. The hypercoagulable state that follows femoral neck
fracture is associated with an increased risk of thromboem-
bolism, and factors enhancing hypercoagulability include,
in addition to the initial trauma, subsequent surgery, blood
loss resulting from either fracture or surgery, and perioper-
ative fluid therapy [74]. Furthermore, the thrombogenic
properties of the bone cement contribute to the pathogenesis
of DVT. Polymethylmethacrylate monomer found in mixed
venous blood during cemented arthroplasty induces secre-
tion of platelet activation factors, such as transforming
growth factor β and β-thromboglobulin, and stimulates
monocytes to express tissue factor, which triggers coagula-
tion [6, 16]. Additionally, higher levels of cytokine
CD14/42a, a known measure of platelet–monocyte aggre-
gation, are present in patients undergoing cemented
arthroplasty [8]. In contrast, a small study by Hong et al.
reported no statistically significant difference in DVT de-
ve lopment be tween cemented and uncemented
hemiarthroplasty prostheses used to treat traumatic
displaced femoral neck fractures (3.0% [n = 4] and 5.1%
[n = 7], respectively) [35].
Clarke et al. studied the bone cement as a risk factor for
DVT, comparing three sets of patients undergoing a
cemented or uncemented total knee replacement (TKR) or
Fig. 6. a Forest plot showing the risk ratio (RR) of pulmonary embo-
lism between cemented and uncemented hemiarthroplasty (with 95%
confidence interval [CI]); b forest plot showing the RR of myocardial
infarction between cemented and uncemented hemiarthroplasty (with
95% CI); c forest plot showing the RR of deep venous thrombosis
between cemented and uncemented hemiarthroplasty (with 95% CI)
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a cemented total hip replacement (THR) [11]. They found
that uncemented prostheses were associated with a greater
prevalence of DVT at 5 to 7 days than cemented prostheses,
and both knee groups had a significantly higher prevalence
of DVT than the cemented THR group. The thrombi were
significantly longer after cemented TKR (26.5 cm) than
after both uncemented TKR (11 cm) and cemented THR
(7 cm). The authors concluded that the bone cement may
influence the length of a thrombus but does not lead to an
increase in the incidence of DVT.
Some study limitations exist. It is possible that unbalanced
cohort sizes and the use of different types of hip prosthesis
limit the study’s power to detect differences between cohorts.
Additionally, comorbidity as a risk factor for death was not
well assessed in all of the included studies. Another limitation
is the inclusion of only English-language literature; relevant
studies in other languages might have been omitted. Finally,
causality cannot be determined in observational studies, lim-
iting the conclusions of our meta-analysis.
In conclusion, current evidence shows patients treated
with cemented hemiarthroplasty experience less postopera-
tive pain than those treated with uncemented prosthesis. Our
meta-analysis shows no significant differences between
cemented and uncemented hip hemiarthroplasty in terms
of functional hip score (the HHS); postoperative mortality;
or medical complications, including pulmonary embolism,
cardiac arrest, myocardial infarction, acute cardiac arrhyth-
mia, and DVT. The absence of a connection between
cemented prostheses and complications is surprising, con-
sidering earlier research findings and the use of cemented
femoral components historically in older patients with poor
bone quality and greater comorbidity. As surgical tech-
niques and perioperative care continue to improve, further
research should be conducted to confirm our findings.
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